Letter: Prostaglandins and catecholamines in gonadotropin secretion.
D000818:Animals; D001241:Aspirin / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects; D002395:Catecholamines / Q000494:pharmacology*; D003864:Depression, Chemical; D004298:Dopamine / Q000494:pharmacology; D005260:Female; D006062:Gonadotropins / Q000378:metabolism*; D006801:Humans; D007031:Hypothalamus / Q000187:drug effects; D007213:Indomethacin / Q000494:pharmacology; D007986:Luteinizing Hormone / Q000378:metabolism; D010053:Ovary / Q000187:drug effects; D010060:Ovulation / Q000187:drug effects; D010643:Phenoxybenzamine / Q000494:pharmacology; D010902:Pituitary Gland / Q000187:drug effects; D011374:Progesterone / Q000494:pharmacology; D011453:Prostaglandins / Q000096:biosynthesis / Q000378:metabolism / Q000494:pharmacology*; D011817:Rabbits; D011863:Radioimmunoassay; D051381:Rats; D013268:Stimulation, Chemical; D014599:Uterus / Q000187:drug effects
D002395:Catecholamines; D006062:Gonadotropins; D011453:Prostaglandins; D010643:Phenoxybenzamine; D011374:Progesterone; D007986:Luteinizing Hormone; D001241:Aspirin; D004298:Dopamine; D007213:Indomethacin